Opendata, web and dolomites

EbolaMoDRAD SIGNED

Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "EbolaMoDRAD" data sheet

The following table provides information about the project.

Coordinator
FOLKHALSOMYNDIGHETEN 

Organization address
address: NOBELS VAG 18
city: SOLNA
postcode: 171 82
website: http://folkhalsomyndigheten.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 4˙300˙935 €
 EC max contribution 4˙300˙935 € (100%)
 Programme 1. H2020-EU.3.1.7.13. (Other)
 Code Call H2020-JTI-IMI2-2014-02-single-stage
 Funding Scheme /IMI2-RIA
 Starting year 2015
 Duration (year-month-day) from 2015-02-01   to  2018-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FOLKHALSOMYNDIGHETEN SE (SOLNA) coordinator 416˙666.00
2    CORIS BIOCONCEPT SPRL BE (GEMBLOUX) participant 318˙125.00
3    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) participant 312˙500.00
4    Department of Health england UK (Leeds) participant 310˙625.00
5    ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE LAZZARO SPALLANZANI-ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO IT (ROMA) participant 308˙750.00
6    THE UNIVERSITY OF STIRLING UK (STIRLING) participant 279˙836.00
7    Clonit srl IT (MILANO) participant 251˙250.00
8    Inserm Transfert FR (PARIS) participant 231˙000.00
9    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 224˙106.00
10    INSTITUT PASTEUR DE DAKAR SN (DAKAR) participant 216˙250.00
11    STATENS SERUM INSTITUT DK (KOBENHAVN S) participant 208˙375.00
12    UNIVERSITE D'AIX MARSEILLE FR (Marseille) participant 207˙084.00
13    STOCKHOLMS UNIVERSITET SE (STOCKHOLM) participant 207˙000.00
14    EMERGENCY LIFE SUPPORT FOR CIVILIAN WAR VICTIMS ONG ONLUS IT (MILANO) participant 200˙078.00
15    AJ INNUSCREEN GMBH DE (BERLIN) participant 175˙000.00
16    INSTITUT PASTEUR FR (PARIS CEDEX 15) participant 173˙040.00
17    HELSINGIN YLIOPISTO FI (HELSINGIN YLIOPISTO) participant 146˙250.00
18    TURUN YLIOPISTO FI (Turku) participant 115˙000.00

Mappa

 Project objective

The current Ebola Virus Disease (EVD) outbreak has caused more than 5000 deaths within a few months in West Africa (Guinea, Sierra Leone and Liberia being the most severely affected countries), including numerous healthcare workers. It is now a serious public health crisis of international concern. The numbers of cases are still increasing 11 months after the first case was described (December 2013): by mid-November 2014 approximately 15000 individuals have been infected and the epidemic is still not under control. The direct effects of this outbreak include disruption of standard medical care, insecurity and social disruption in countries that were already struggling to recover from decades of war. One of the most important key actions to limit and stop the spread of this deadly disease is to identify and isolate the EBOV-infected patients. The diagnosis of Ebola Virus infections has in the past, been performed overwhelmingly in specialist reference laboratories with high-performance molecular, serological and culture methods. In recent years many of these functions have been mobilised into rapid response mobile laboratories. Indeed several of these units supported by European, CDC/USA, Canadian, Chinese and African states have been set up to help the current outbreak by performing laboratory diagnosis, in collaboration with national centres in West Africa. While this type of response has been effective in helping control past EVD outbreaks in rural parts of Africa, it has not been as effective at controlling the current outbreak, which is now spreading in densely populated city and slum areas. Unfortunately, the diagnostic procedures currently used in the mobile laboratories are associated with several problems: i) there are a limited number of diagnostic hubs, ii) performing the diagnostic tests correctly requires specialist training, skill and experience, consequently there a limited numbers of trained staff, iii) the distance between the point of care and diagnostic hubs means that patients cannot be rapidly isolated and thus spread the virus and iv) there are serious biosafety aspects of handling and transporting hazard group 4 infectious samples from hospitals/emergency medical units to the diagnostic hubs. The EbolaMoDRAD project plans to investigate and focus our activities on developing robust, sensitive and rapid diagnostic tools that can be used at the point of care for field investigation. The complexity of the technical issues to be addressed requires a broad and multidisciplinary network of experts. EbolaMoDRAD will build existing leading-edge expertise in Europe and Africa, and bring these together with new networks of scientists who will work towards solving important public health issues concerning EVD that cannot be resolved by individual groups. The overall aim of EbolaMoDRAD is to develop and deliver rapid bedside diagnostic tool(s) that will significantly increase our capacity to handle the current situation of EVD in West Africa and also future outbreaks, within a 24 month period. The project will be a multidisciplinary research consortium drawn from key European and African research organisations, thus consolidating previous tools and knowledge. EbolaMoDRAD will also put in place a strong capacity building programme in West Africa and hands-on training in non-endemic countries (neighbouring to endemic areas) in the fields of outbreak management, diagnostics and application of EbolaMoDRAD tools/results. EbolaMoDRAD will disseminate widely all results as they become available notably to public health bodies, NGOs, outbreak management teams and local hospitals in West Africa via a strong outreach programme. To achieve this overall aim, an intensive work plan will be put in place with the following specific objectives: • To develop a biosafe rapid detection method (diagnostic tool) for a use at points of care in EVD endemic countries; • To validate the diagnostic tools first in BSL4 and reference lab

 Work performed, outcomes and results:  advancements report(s) 

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EBOLAMODRAD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EBOLAMODRAD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.13.)

eTRANSAFE (2017)

Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management

Read More  

EBOVAC1 (2014)

Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen

Read More  

EBODAC (2014)

Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.

Read More